BCTX

Briacell Therapeutics Corp. Common Shares

$3.31 -9.07%

Recent alerts on BCTX

All signals →

Short volume Short volume 68% of volume (4.2σ)

News BriaCell Therapeutics Announces Closing of US$30 million Public Offering

News Brenig Therapeutics Announces Initiation of First-in-Human Study of BT-409, a Brain-Selective NLRP3 Inhibitor, and Provides Update on BT-267, its LRRK2 Program

News BrianCell Therapeutics drops 10%, prices $30M offering at $5.59 per unit

News BriaCell Therapeutics Announces Pricing of $30 million Public Offering

Get push alerts for BCTX

Add it to your watchlist in the app and receive every signal the moment it fires.

Download for iOS

Download for iOS